Duygu Kuzuoğlu-Öztürk

7PUBLICATIONS
65CO-AUTHORS
GlycoconjugatesInnate immunityMechanobiologyMolecular targetsCell metabolism
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2025
Programmable translational inhibition by a molecular glue-oligonucleotide conjugate.

Siyi Wang, Joanna R Kovalski, Francisco J Zapatero-Belinchón

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

|Jul 26, 2023
Evolutionarily divergent mTOR remodels translatome for tissue regeneration.

Olena Zhulyn, Hannah D Rosenblatt, Leila Shokat

|Dec 08, 2022
PHGDH and cancer: new job for an old enzyme!

Duygu Kuzuoglu-Ozturk

|Oct 20, 2022
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.

Duygu Kuzuoglu-Ozturk, Ozlem Aksoy, Christin Schmidt

|Mar 22, 2022
Protein synthesis control in cancer: selectivity and therapeutic targeting.

Joanna R Kovalski, Duygu Kuzuoglu-Ozturk, Davide Ruggero

Pageof 2